Gencurix Inc. (KOSDAQ:229000)
South Korea · Delayed Price · Currency is KRW 1,606.00
-32.00 (-1.95%)
Aug 29, 2025, 12:36 PM KST
Gencurix Company Description
Gencurix Inc. provides diagnostic solutions in South Korea.
Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection.
The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform.
The company was founded in 2011 and is headquartered in Seoul, South Korea.
Gencurix Inc.
| Country | South Korea |
| Founded | 2011 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| CEO | Sung-Rai Cho |
Contact Details
Address: Hanhwa Bizmetro Seoul, 152-733 South Korea | |
| Phone | 82 2 2621 7038 |
| Website | gencurix.com |
Stock Details
| Ticker Symbol | 229000 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7229000005 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Sung-Rai Cho | Chief Executive Officer |